Fedor V Moiseyenko (Fedor Moiseenko)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of molecular sciences

Future oncology (London, England)

Current treatment options in oncology

This page only lists publications with an associated author ORCID identifier.

Publications

D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Fedor V Moiseyenko, Ekatherina Sh Kuligina, Ekaterina Elsakova, Evgeny N Imyanitov
Epidermal growth factor receptor-mutated lung carcinomas with insufficient response to epidermal growth factor receptor inhibitors. Future oncology (London, England) (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor V Moiseyenko, Elena Filippova, Irfan Cicin, Tudor Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope Bradbury, Mor Moskovitz, Nuran Katgi, Pascale Tomasini, Alona Zer Kuch, Nicolas Girard, Kristof Cuppens, Ji-Youn Han, Shang-Yin Wu, Shobhit Baijal, Aaron S Mansfield, Allen Chung-Cheng Huang, Kazumi Nishino, Se-Hoon Lee, David Planchard, Christina Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine Ratajczak, Shun Lu
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Anna P Sokolenko, Fedor V Moiseyenko, Aglaya G Iyevleva, Alexandr O Ivantsov, Georgiy D Dolmatov, Ksenia V Shelekhova, Elizaveta V Gulo, Anastasya X Topal, Elizaveta V Artemieva, Nuriniso H Abduloeva, Nikita A Rysev, Daria A Barsova, Natalia V Levchenko, Nikita M Volkov, Vitaliy V Egorenkov, Vladimir M Moiseyenko, Evgeny N Imyanitov
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients. International journal of molecular sciences 24 (3) (2023)
Anna P Sokolenko, Fedor V Moiseyenko, Aglaya G Iyevleva, Alexandr O Ivantsov, Georgiy D Dolmatov, Ksenia V Shelekhova, Elizaveta V Gulo, Anastasya X Topal, Elizaveta V Artemieva, Nuriniso H Abduloeva, Nikita A Rysev, Daria A Barsova, Natalia V Levchenko, Nikita M Volkov, Vitaliy V Egorenkov, Vladimir M Moiseyenko, Evgeny N Imyanitov
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients. International journal of molecular sciences 24 (3) (2023)
Anna P Sokolenko, Fedor V Moiseyenko, Aglaya G Iyevleva, Alexandr O Ivantsov, Georgiy D Dolmatov, Ksenia V Shelekhova, Elizaveta V Gulo, Anastasya X Topal, Elizaveta V Artemieva, Nuriniso H Abduloeva, Nikita A Rysev, Daria A Barsova, Natalia V Levchenko, Nikita M Volkov, Vitaliy V Egorenkov, Vladimir M Moiseyenko, Evgeny N Imyanitov
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients. International journal of molecular sciences 24 (3) (2023)
Fedor V Moiseyenko, Ekatherina Sh Kuligina, Albina S Zhabina, Sergey A Belukhin, Tatiana A Laidus, Aleksandr S Martianov, Kirill A Zagorodnev, Tatyana N Sokolova, Svetlana A Chuinyshena, Maksim M Kholmatov, Elizaveta V Artemieva, Ekaterina O Stepanova, Tatiana N Shuginova, Nikita M Volkov, Grigoriy A Yanus, Evgeny N Imyanitov
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer. International journal of clinical oncology 27 (5) (2022)
Fedor V Moiseyenko, Alexey Bogdanov, Vitaliy Egorenkov, Nikita Volkov, Vladimir Moiseyenko
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance. Current treatment options in oncology (2022)
David F Heigener, Keith M Kerr, Gavin M Laing, Tony S K Mok, Fedor V Moiseyenko, Martin Reck
Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (16) (2019)